The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Paclitaxel: a review of adverse toxicities and novel delivery strategies
Abstract
Better known as Taxol (Bristol-Myers Squibb), paclitaxel is the first member of the taxane family to be used in cancer chemotherapy. The taxanes exert their cytotoxic effect by arresting mitosis through microtubule stabilization, resulting in cellular apoptosis. The use of paclitaxel as a chemotherapeutic agent has become a broadly accepted option in the treatment of patients with ovarian, breast and non-small cell lung cancers, malignant brain tumors, and a variety of other solid tumors. However, significant toxicities, such as myelosuppression and peripheral neuropathy, limit the effectiveness of paclitaxel-based treatment regimens. This review addresses the toxicities associated with paclitaxel treatment and describes existing and future strategies of paclitaxel administration directed at limiting these toxicities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Armstrong, D. K., Bundy, B., Wenzel, L., Huang, H. Q., Baergen, R., Lele, S., Copeland, L. J., Walker, J. L., & Burger, R. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052985 · Cited by 2,625
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Structure of the αβ tubulin dimer by electron crystallography
Nogales, E., Wolf, S. G., & Downing, K. H. (1998) · Nature · doi:10.1038/34465 · Cited by 2,076
Taxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
Rowinsky, E. K., & Donehower, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321507 · Cited by 1,924
Ward, A., & Clissold, S. P. (1987) · Drugs · doi:10.2165/00003495-198734010-00003 · Cited by 1,754
Gelderblom, H., Verweij, J., Nooter, K., & Sparreboom, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00171-x · Cited by 1,655
Westphal, M., Hilt, D. C., Bortey, E., Delavault, P., Olivares, R., Warnke, P. C., Whittle, I. R., Jääskeläinen, J., & Ram, Z. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.79 · Cited by 1,330
Desai, N., Trieu, V., Yao, Z., Louie, L., Ci, S., Yang, A., Tao, C., De, T., Beals, B., Dykes, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1634 · Cited by 1,175
Hypersensitivity reactions from taxol.
Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., & Leyland-Jones, B. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1263 · Cited by 1,174
Sindrup, S. H., & Jensen, T. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00154-2 · Cited by 1,144
Taxol: A Novel Investigational Antimicrotubule Agent
Rowinsky, E. K., Cazenave, L. A., & Donehower, R. C. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.15.1247 · Cited by 1,090
Kim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., Kim, N. K., & Bang, Y.-J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0655 · Cited by 821
Fonseca, C., Simões, S., & Gaspar, R. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00212-2 · Cited by 755
Ibrahim, N. K., Desai, N. P., Legha, S. S., Soon‐Shiong, P., Theriault, R. L., Rivera, E., Esmaeli, B., Ring, S. E., Bedikian, A. Y., Hortobágyi, G. N., et al. (2002) · PubMed · Cited by 705
The microtubule-affecting drug paclitaxel has antiangiogenic activity.
Belotti, D., Vergani, V., Drudis, T., Borsotti, P., Pitelli, M. R., Viale, G., Giavazzi, R., & Taraboletti, G. (1996) · PubMed · Cited by 643
Eisenhauer, E. A., ten Bokkel Huinink, W. W., Swenerton, K. D., Gianni, L., Myles, J., van der Burg, M. E., Kerr, I., Vermorken, J. B., Buser, K., & Colombo, N. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.12.2654 · Cited by 626
Gianni, L., Kearns, C. M., Giani, A., Capri, G., Viganó, L., Lacatelli, A., Bonadonna, G., & Egorin, M. J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.180 · Cited by 553
Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas
Brem, H., Mahaley, M. S., Vick, N. A., Black, K. L., Schold, S. C., Burger, P. C., Friedman, A. H., Ciric, I. S., Eller, T. W., Cozzens, J. W., et al. (1991) · Journal of Neurosurgery · doi:10.3171/jns.1991.74.3.0441 · Cited by 488
Self-citationYukimune, Y., Tabata, H., Higashi, Y., & Hara, Y. (1996) · Nature Biotechnology · doi:10.1038/nbt0996-1129 · Cited by 474
Microtubule-targeted anticancer agents and apoptosis
Bhalla, K. N. (2003) · Oncogene · doi:10.1038/sj.onc.1207233 · Cited by 461
Phase I clinical and pharmacokinetic study of taxol.
Wiernik, P. H., Schwartz, E. L., Strauman, J. J., Dutcher, J. P., Lipton, R. B., & Paietta, E. M. (1987) · PubMed · Cited by 455
Multi-pulse drug delivery from a resorbable polymeric microchip device
Grayson, A. C. R., Choi, I. S., Tyler, B. M., Wang, P. P., Brem, H., Cima, M. J., & Langer, R. (2003) · Nature Materials · doi:10.1038/nmat998 · Cited by 444
Self-citationSequences of taxol and cisplatin: a phase I and pharmacologic study.
Rowinsky, E. K., Gilbert, M. R., McGuire, W. P., Noe, D. A., Grochow, L. B., Forastiere, A. A., Ettinger, D. S., Lubejko, B. G., Clark, B., & Sartorius, S. E. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.9.1692 · Cited by 426
Poly(l-glutamic acid)–anticancer drug conjugates
Li, C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00045-5 · Cited by 414
Taxol binds to cellular microtubules.
Manfredi, J. J., Parness, J., & Horwitz, S. B. (1982) · The Journal of cell biology · doi:10.1083/jcb.94.3.688 · Cited by 409
Bunn, P. A., & Kelly, K. L. (1998) · PubMed · Cited by 400
Spencer, C. M., & Faulds, D. (1994) · Drugs · doi:10.2165/00003495-199448050-00009 · Cited by 396
Cardiac disturbances during the administration of taxol.
Rowinsky, E. K., McGuire, W. P., Guarnieri, T., Fisherman, J. S., Christian, M. C., & Donehower, R. C. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.9.1704 · Cited by 395
Taxol: the first of the taxanes, an important new class of antitumor agents.
Rowinsky, E. K., Onetto-Pothier, N., Canetta, R. M., & Arbuck, S. G. (1992) · PubMed · Cited by 389
Structure of tubulin at 6.5 Å and location of the taxol-binding site
Nogales, E., Grayer Wolf, S., Khan, I. A., Ludueña, R. F., & Downing, K. H. (1995) · Nature · doi:10.1038/375424a0 · Cited by 389
A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel
Ruel-Gariépy, E., Shive, M., Bichara, A., Berrada, M., Le Garrec, D., Chenite, A., & Leroux, J.-C. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00095-x · Cited by 379
Seidman, A. D., Hudis, C. A., Albanell, J., Albanel, J., Tong, W., Tepler, I., Currie, V, Moynahan, M. E., Theodoulou, M., Gollub, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3353 · Cited by 378
Chaudhry, V., Rowinsky, E. K., Sartorius, S. E., Donehower, R. C., & Cornblath, D. R. (1994) · Annals of Neurology · doi:10.1002/ana.410350310 · Cited by 363
The binding conformation of Taxol in β-tubulin: A model based on electron crystallographic density
Snyder, J. P., Nettles, J. H., Cornett, B., Downing, K. H., & Nogales, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051309398 · Cited by 362
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo
Fellner, S., Bauer, B., Miller, D. S., Schaffrik, M., Fankhänel, M., Spruß, T., Bernhardt, G., Graeff, C., Färber, L., Gschaidmeier, H., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15451 · Cited by 359
Characterization of thermosensitive chitosan gels for the sustained delivery of drugs
Ruel-Gariépy, E., Chenite, A., Chaput, C., Guirguis, S., & Leroux, J.-C. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00428-2 · Cited by 346
Advancing the field of drug delivery
Moses, M. A., Brem, H., & Langer, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00276-9 · Cited by 343
Self-citationLidar, Z., Mardor, Y., Jonas, T., Pfeffer, R., Faibel, M., Nass, D., Hadani, M., & Ram, Z. (2004) · Journal of Neurosurgery · doi:10.3171/jns.2004.100.3.0472 · Cited by 342
Szebeni, J., Alving, C. R., & Muggia, F. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.4.300 · Cited by 341
(1999) · PubMed · Cited by 337
Mu, L., & Feng, S. S. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00025-1 · Cited by 328
Taxol produces a predominantly sensory neuropathy
Lipton, R. B., Apfel, S. C., Dutcher, J. P., Rosenberg, R., Kaplan, J., Berger, A., Einzig, A. I., Wiernik, P., & Schaumburg, H. H. (1989) · Neurology · doi:10.1212/wnl.39.3.368 · Cited by 318
Sparreboom, A., van Tellingen, O., Nooijen, W. J., & Beijnen, J. H. (1996) · PubMed · Cited by 313
Ruel-Gariépy, E., Leclair, G., Hildgen, P., Gupta, A., & Leroux, J.-C. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00146-3 · Cited by 308
Cragg, G. M., Schepartz, S. A., Suffness, M., & Grever, M. R. (1993) · Journal of Natural Products · doi:10.1021/np50100a001 · Cited by 308
Nyman, D. W., Campbell, K. J., Hersh, E., Long, K., Richardson, K., Trieu, V., Desai, N., Hawkins, M. J., & Von Hoff, D. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.6148 · Cited by 286
Shared Actions of Endotoxin and Taxol on TNF Receptors and TNF release
Ding, A. H., Porteu, F., Sanchez, E., & Nathan, C. F. (1990) · Science · doi:10.1126/science.1970196 · Cited by 281
Multicenter Phase II Trial of Weekly Paclitaxel in Women With Metastatic Breast Cancer
Perez, E. A., Vogel, C. L., Irwin, D. H., Kirshner, J. J., & Patel, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.22.4216 · Cited by 250
Tamargo, R. J., Myseros, J. S., Epstein, J. I., Yang, M. B., Chasin, M., & Brem, H. (1993) · PubMed · Cited by 247
Self-citationTargeted therapy for brain tumours
Lesniak, M. S., & Brem, H. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1414 · Cited by 234
Self-citationWalter, K. A., Cahan, M. A., Gur, A., Tyler, B., Hilton, J., Colvin, O. M., Burger, P. C., Domb, A. J., & Brem, H. (1994) · PubMed · Cited by 231
Self-citationRodi, D. J., Janes, R. W., Sanganee, H. J., Holton, R. A., Wallace, B. A., & Makowski, L. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2303 · Cited by 223
Wang, J., Lou, P., Lesniewski, R., & Henkin, J. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200301000-00003 · Cited by 212
Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients
Tellingen, O. V., Huizing, M. T., Panday, V. R. N., Schellens, J. H. M., Nooijen, W. J., & Beijnen, J. H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690696 · Cited by 211
Vitamin E for prophylaxis against chemotherapy-induced neuropathy: A randomized controlled trial
Argyriou, A. A., Chroni, E., Koutras, A., Ellul, J., Papapetropoulos, S., Katsoulas, G., Iconomou, G., & Kalofonos, H. P. (2005) · Neurology · doi:10.1212/01.wnl.0000148609.35718.7d · Cited by 209
Brem, H., Ewend, M. G., Piantadosi, S., Greenhoot, J., Burger, P. C., & Sisti, M. (1995) · Journal of Neuro-Oncology · doi:10.1007/bf01060217 · Cited by 209
Self-citationRowinsky, E. K., Chaudhry, V., Cornblath, D. R., & Donehower, R. C. (1993) · PubMed · Cited by 208
Taxol Induces Caspase-10-dependent Apoptosis
Park, S.-J., Wu, C.-H., Gordon, J. D., Zhong, X., Emami, A., & Safa, A. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406543200 · Cited by 198
A reassessment of cardiac toxicity associated with Taxol.
Arbuck, S. G., Strauss, W. H., Rowinsky, E. K., Christian, M. C., Suffness, M., Adams, J., Oakes, M., McGuire, W. P., Reed, E., & Gibbs, H. H. (1993) · PubMed · Cited by 195
Rowinsky, E. K., Chaudhry, V, Forastiere, A. A., Sartorius, S. E., Ettinger, D. S., Grochow, L. B., Lubejko, B. G., Cornblath, D. R., & Donehower, R. C. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.2010 · Cited by 192
Peripheral neuropathy: A persisting challenge in paclitaxel-based regimes
Mielke, S., Sparreboom, A., & Mross, K. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.06.030 · Cited by 186
Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
Bradley, M. O., Webb, N. L., Anthony, F. H., Devanesan, P. D., Witman, P. A., Hemamalini, S., Chander, M. C., Baker, S. D., He, L., Horwitz, S. B., et al. (2001) · PubMed · Cited by 180
von Haefen, C., Wieder, T., Essmann, F., Schulze-Osthoff, K., Dörken, B., & Daniel, P. T. (2003) · Oncogene · doi:10.1038/sj.onc.1206280 · Cited by 177
The role of MAPK pathways in the action of chemotherapeutic drugs
Boldt, S. (2002) · Carcinogenesis · doi:10.1093/carcin/23.11.1831 · Cited by 175
Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia
Sissung, T. M., Mross, K., Steinberg, S. M., Behringer, D., Figg, W. D., Sparreboom, A., & Mielke, S. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.06.017 · Cited by 170
Singer, J. W., Baker, B., de Vries, P., Kumar, A., Shaffer, S., Vawter, E., Bolton, M., & Garzone, P. D. (2004) · Advances in experimental medicine and biology · doi:10.1007/0-306-47932-x_6 · Cited by 168
Stone, A. A., & Chambers, T. C. (2000) · Experimental Cell Research · doi:10.1006/excr.1999.4731 · Cited by 166
Recent advances in drug-induced neuropathies
Peltier, A. C., & Russell, J. W. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200210000-00015 · Cited by 165
Clinical Pharmacokinetics of Paclitaxel
Sonnichsen, D. S., & Relling, M. V. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427040-00002 · Cited by 163
Taxol Neuropathy: Electrodiagnostic and Sural Nerve Biopsy Findings
Sahenk, Z. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540190110024 · Cited by 163
Mechanism-Based Pharmacokinetic Model for Paclitaxel
Henningsson, A., Karlsson, M. O., Viganò, L., Gianni, L., Verweij, J., & Sparreboom, A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.20.4065 · Cited by 156
Wang, C., Wu, J., & Mei, X. (2001) · Applied Microbiology and Biotechnology · doi:10.1007/s002530000567 · Cited by 154
Mielke, S., Sparreboom, A., Steinberg, S. M., Gelderblom, H. A. J., Unger, C., Behringer, D. M., & Mross, K. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0298 · Cited by 144
In vivo release from a drug delivery MEMS device
李雅文, Shawgo, R. S., Tyler, B., Henderson, P. T., Vogel, J. S., Rosenberg, A., Storm, P. B., Langer, R., Brem, H., & Cima, M. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.018 · Cited by 131
Self-citationOfir, R., Seidman, R., Rabinski, T., Krup, M., Yavelsky, V., Weinstein, Y., & Wolfson, M. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401012 · Cited by 129
Huisman, C., Ferreira, C. G., Bröker, L. E., Rodríguez, J. A., Smit, E. F., Postmus, P. E., Kruyt, F. A. E., & Giaccone, G. (2002) · PubMed · Cited by 129
Tudor, G., Aguilera, A., Halverson, D. O., Laing, N., & Sausville, E. A. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400688 · Cited by 122
Okano, J., & Rustgi, A. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011164200 · Cited by 121
Harper, E., Dang, W., Lapidus, R. G., & Garver, R. I. (1999) · PubMed · Cited by 120
Joerger, M., Huitema, A. D. R., van den Bongard, H. J. G. D., Schellens, J. H. M., & Beijnen, J. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2069 · Cited by 120
Cytotoxicity of taxol in vitro against human and rat malignant brain tumors
Cahan, M. A., Walter, K. A., Colvin, O. M., & Brem, H. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686276 · Cited by 116
Self-citationCalpain inhibition protects against Taxol-induced sensory neuropathy
Wang, M. S. (2003) · Brain · doi:10.1093/brain/awh078 · Cited by 116
Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
Li, C., Price, J. E., Milas, L., Hunter, N. R., Shi, K., Yu, D. F., Charnsangavej, C., & Wallace, S. (1999) · PubMed · Cited by 114
Stimulation of Erythrocyte Phosphatidylserine Exposure by Paclitaxel
Lang, P. A., Huober, J., Bachmann, C., Kempe, D. S., Sobiesiak, M., Akel, A., Niemoeller, O. M., Dreischer, P., Eisele, K., Klarl, B. A., et al. (2006) · Cellular Physiology and Biochemistry · doi:10.1159/000095190 · Cited by 112
Phase I trial of weekly paclitaxel in advanced lung cancer.
Akerley, W. A., Glantz, M., Choy, H., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.153 · Cited by 110
Theiß, C., & Meller, K. (2000) · Cell and Tissue Research · doi:10.1007/s004410050019 · Cited by 110
Successful parenteral desensitization to paclitaxel
Essayan, D. M., Kagey‐Sobotka, A., Colarusso, P., Lichtenstein, L. M., Ozols, R. F., & King, E. D. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70281-6 · Cited by 109
Theiß, C., & Meller, K. (1999) · Cell and Tissue Research · doi:10.1007/s004419900120 · Cited by 108
Production of Paclitaxel and the Related Taxanes by Cell Suspension Cultures of Taxus Species
Tabata, H. (2006) · Current Drug Targets · doi:10.2174/138945006776359368 · Cited by 103
Li, C., Shi, K., Wu, Q., Tansey, W., Hunter, N. R., Buchmiller, L., Milas, L., Charnsangavej, C., & Wallace, S. (2000) · PubMed · Cited by 102
Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel.
Gelderblom, H. A. J., Verweij, J., van Zomeren, D. M., Buijs, D., Ouwens, L., Nooter, K., Stoter, G., & Sparreboom, A. (2002) · PubMed · Cited by 99
Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein.
Kumar, G. N., Walle, U. K., Bhalla, K. N., & Walle, T. (1993) · PubMed · Cited by 98
In vivo delivery of BCNU from a MEMS device to a tumor model
李雅文, Duc, H. L. H., Tyler, B., Williams, T., Tupper, M. M., Langer, R., Brem, H., & Cima, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.009 · Cited by 96
Self-citationCremophor EL, solvent for paclitaxel, and toxicity
Liebmann, J., Cook, J., & Mitchell, J. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)92789-v · Cited by 85
Wolff, A. C., Donehower, R. C., Carducci, M., Carducci, M. A., Brahmer, J. R., Zabelina, Y., Bradley, M. O., Anthony, F. H., Swindell, C. S., Witman, P. A., et al. (2003) · PubMed · Cited by 80
Paclitaxel (Taxol) induces cumulative mild neurotoxicity
van Gerven, J., Moll, J. W. B., van den Bent, M. J., Bontenbal, M., van der Burg, M. E. L., Verweij, J., & Vecht, C. J. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90459-6 · Cited by 77
Armstrong, D. K., Fleming, G. F., Markman, M. M., et al. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.02.029 · Cited by 75
Huang, Y. K., Sheikh, M. S., Fornace, A. J., & Holbrook, N. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202685 · Cited by 71
Walter, K. A., Tamargo, R. J., Olivi, A., Burger, P. C., & Brem, H. (1995) · Neurosurgery · doi:10.1097/00006123-199512000-00013 · Cited by 68
Self-citationPolilactofate microspheres for Paclitaxel delivery to central nervous system malignancies.
Li, K. W., Dang, W., Tyler, B., Troiano, G., Tihan, T., Brem, H., & Walter, K. A. (2003) · PubMed · Cited by 65
Self-citationStadheim, T. A., Xiao, H., & Eastman, A. R. (2001) · PubMed · Cited by 63
Lu, H., Li, B., Kang, Y., Jiang, W., Huang, Q., Chen, Q., Li, L., & Xu, C. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0256-z · Cited by 63
Akerley, W., Herndon, J. E., Egorin, M. J., Lyss, A. P., Kindler, H. L., Savarese, D. M. F., Sherman, C. A., Rosen, D. M., Hollis, D. R., Ratain, M. J., et al. (2003) · Cancer · doi:10.1002/cncr.11375 · Cited by 61
Enhancement of paclitaxel production by temperature shift in suspension culture of Taxus chinensis
Choi, H., Kim, S., Son, J.-S., et al. (2000) · Enzyme and Microbial Technology · doi:10.1016/s0141-0229(00)00255-6 · Cited by 46
Buahin, K. G., & Brem, H. (1995) · Journal of Neuro-Oncology · doi:10.1007/bf01060216 · Cited by 45
Self-citationRichards, D., Richards, P. D., Bodkin, D., Neubauer, M., & Oldham, F. B. (2005) · Clinical Lung Cancer · doi:10.3816/clc.2005.n.039 · Cited by 28
Harries, M., O’Donnell, A. E., Scurr, M. R., Reade, S., Cole, C., Judson, I. R., Greystoke, A., Twelves, C. J., & Kaye, S. B. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602196 · Cited by 27
Apfel, S. C. (2000) · Cancer Investigation · doi:10.3109/07357900009012196 · Cited by 27
Boudný, V., & Nakano, S. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600080 · Cited by 27
(1998) · PubMed · Cited by 26
Chemotherapy of non-small-cell lung cancer: Role of erythropoietin in the management of anemia
Mastro, L. D., Gennari, A., & Donati, S. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_5.s91 · Cited by 25
Induction of expression of inducible nitric oxide synthase by Taxol in murine macrophage cells
Kim, Y. M., & Paik, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.043 · Cited by 19
Cited by
Recent advances of cocktail chemotherapy by combination drug delivery systems
Hu, Q., Sun, W., Wang, C., & Gu, Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.022 · Cited by 625
Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
Abu Samaan, T. M., Samec, M., Liskova, A., Kubatka, P., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9120789 · Cited by 569
Engineered exosomes from different sources for cancer-targeted therapy
Zhang, M., Hu, S., Liu, L., Dang, P., Liu, Y., Sun, Z., Qiao, B., & Wang, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01382-y · Cited by 468
Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona
Blume, J. E., Manning, W. C., Troiano, G., Hornburg, D., Figa, M., Hesterberg, L., Platt, T. L., Zhao, X., Cuaresma, R. A., Everley, P. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17033-7 · Cited by 452
Paclitaxel: What has been done and the challenges remain ahead
Bernabeu, E., Cagel, M., Lagomarsino, E., Moretton, M., & Chiappetta, D. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.016 · Cited by 413
Metadata
- Authors
- Marupudi, N. I., Han, J. E., Li, K. W., Renard, V. M., Tyler, B. M., & Brem, H.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa Healthcare
- Published
- 2007-09
- Volume
- 6
- Issue
- 5
- Pages
- 609-621
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2154054522
- Cited by
- 510
- References
- 115
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.